TelyRx Holdings Inc. shares surged by over 22% in the latest trading session, reflecting strong investor interest.
In a remarkable one-day performance, TelyRx Holdings Inc. (TELY.TO) saw its stock price jump by 22.45%, closing at CA$3.00. This surge comes amid increasing investor enthusiasm following the company's recent developments.
Investor takeaway: Investors should consider the implications of TelyRx's stock surge and monitor any forthcoming announcements that could impact its trajectory.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$65.12M
52W high
$4.25
52W low
$2.00
1W change
+25.00%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 100.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+100.0% Upside
Current Price
C$3.00
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.2%
Annualized
90-Day Vol
100.3%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$3.00
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$3.00 | C$2.11 โ C$4.27 |
| 60 trading days | C$3.00 | C$1.82 โ C$4.94 |
| 90 trading days | C$3.00 | C$1.63 โ C$5.52 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
TelyRx Holdings Inc. Stock Up 22.45%
With a market cap of CA$65.12 million, TelyRx's significant one-day gain highlights its potential volatility and investor interest.
Bull case
The recent spike in TelyRx's stock price suggests that investors are growing more confident in the company's future. This optimism follows TelyRx's transition to the Toronto Stock Exchange and its recent financial disclosures, which may have reassured investors about its prospects.
Bear case
Despite the positive movement, TelyRx's ongoing losses and lack of dividends could raise concerns about its long-term sustainability and profitability. Investors should weigh these risks carefully before making decisions.
Advertisement
